REVOLUTION MEDICINES INC. - COMMON STOCK

Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress

10 ноя 2021 15:05:01 Источник Nasdaq GlobeNewswire

Revolution Medicines to Participate in Stifel 2021 Virtual Healthcare Conference

08 ноя 2021 15:05:00 Источник Nasdaq GlobeNewswire

Revolution Medicines to Report Financial Results for Third Quarter 2021 After Market Close on November 10, 2021

03 ноя 2021 15:05:00 Источник Nasdaq GlobeNewswire

Revolution Medicines to Present New Preclinical Data from RAS(ON) Inhibitor Programs at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

30 сен 2021 06:30:00 Источник Nasdaq GlobeNewswire

Revolution Medicines to Participate in 3rd Annual RAS-Targeted Drug Development Summit

15 сен 2021 06:30:00 Источник Nasdaq GlobeNewswire

Revolution Medicines to Present at H.C. Wainwright 23rd Annual Global Investment Conference

07 сен 2021 15:05:00 Источник Nasdaq GlobeNewswire

Revolution Medicines Reports Second Quarter Financial Results and Update on Corporate Progress

11 авг 2021 15:01:00 Источник Nasdaq GlobeNewswire

Revolution Medicines to Report Financial Results for Second Quarter 2021 After Market Close on August 11, 2021

04 авг 2021 15:05:00 Источник Nasdaq GlobeNewswire

Revolution Medicines Announces Publication of Scientific Paper Describing Novel Class of Anti-Tumor Compounds Targeting mTORC1

24 июн 2021 15:05:00 Источник Nasdaq GlobeNewswire

Revolution Medicines to Host Science Talk Webcast Highlighting Learnings from Recent Preclinical and Clinical Studies of RAS Inhibitors

10 июн 2021 06:30:00 Источник Nasdaq GlobeNewswire

Revolution Medicines to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference

02 июн 2021 06:30:00 Источник Nasdaq GlobeNewswire

Revolution Medicines to Participate in Cowen 2nd Annual Virtual Oncology Innovation Summit

18 май 2021 06:30:00 Источник Nasdaq GlobeNewswire

Revolution Medicines Reports First Quarter Financial Results and Update on Corporate Progress

10 май 2021 15:05:00 Источник Nasdaq GlobeNewswire

Revolution Medicines Highlights Slate of Diverse Board of Directors Nominees for Upcoming 2021 Annual Shareholder Meeting

03 май 2021 06:05:00 Источник Nasdaq GlobeNewswire

Revolution Medicines Announces Dosing of First Patient in Phase 1/1b Clinical Study of RMC-5552 in Patients with Advanced Solid Tumors

21 апр 2021 06:00:00 Источник Nasdaq GlobeNewswire

Revolution Medicines Announces Six Presentations at the American Association for Cancer Research Annual Meeting 2021

11 мар 2021 15:05:01 Источник Nasdaq GlobeNewswire

Revolution Medicines to Participate in Upcoming Investor Conferences

09 мар 2021 06:30:00 Источник Nasdaq GlobeNewswire

Revolution Medicines Reports Fourth Quarter and Year-End 2020 Financial Results and Update on Corporate Progress

02 мар 2021 15:05:00 Источник Nasdaq GlobeNewswire

Revolution Medicines to Participate in Digital RAS-Targeted Drug Discovery Summit and Upcoming Investor Conferences

18 фев 2021 06:30:00 Источник Nasdaq GlobeNewswire

Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

08 фев 2021 15:01:00 Источник Nasdaq GlobeNewswire